Replies to post #217236 on Biotech Values

[DewDiligence]

CDMO—(f/k/a PPHM)—sells 10.35M* shares@$2.25—a 31% discount to yesterday’s close:

https://finance.yahoo.com/news/avid-bioservices-announces-pricing-public-100000870.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

PPHM post-mortem—from 2012 (#msg-79442668):

The results are great and so is management.

…Anti-PS will fill any companies [sic] pipeline for the next 30 years…

…Would you want your competition to DOMINATE THE ONCOLOGY MARKET FOR THE NEXT 30 YEARS? Any BP who can corner the PS technology will consider it a bargain to pay $40-$50 Billion…

As it turned out, the IP wasn't worth $40-50B, but it was worth $8M (#msg-138471299).

Rounding error?